Delay in progression of malignant lymphoma after BCG vaccination.
D000328:Adult; D001500:BCG Vaccine; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000276:immunology / Q000473:pathology / Q000628:therapy; D006801:Humans; D008223:Lymphoma / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009107:Mumps / Q000276:immunology; D012075:Remission, Spontaneous; D013997:Time Factors; D014374:Tuberculin Test
D001500:BCG Vaccine